Skip to content
Trial Eligibility
Menu

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

NCT06808984

This study is recruiting at 32 US sites in 16 states, according to its ClinicalTrials.gov record last updated .

Summary

This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Agitation
  • Alzheimer Disease

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
55 to 90 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Celgene
Last updated on ClinicalTrials.gov
October 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • University of Alabama - Huntsville Regional Medical Campus · Huntsville, AL

California · 4

  • Inland Psychiatric Medical Group. · Chino, CA
  • Kaizen Brain Center · La Jolla, CA
  • Shreenath Clinical Service - Lakewood · Lakewood, CA
  • Next Level Clinical Trials · West Covina, CA

Colorado · 1

  • University of Colorado Anschutz Medical Campus · Aurora, CO

District of Columbia · 1

  • Georgetown University · Washington D.C., DC

Florida · 4

  • Arrow Clinical Trials · Daytona Beach, FL
  • ClinCloud · Maitland, FL
  • University of South Florida, Department of Psychiatry and Behavioral Neurosciences · Tampa, FL
  • Charter Research - Lady Lake · The Villages, FL

Georgia · 2

  • CenExel iResearch, LLC · Decatur, GA
  • CenExel iResearch, LLC · Savannah, GA

Massachusetts · 1

  • K2 Medical Research · Foxborough, MA

Nebraska · 1

  • Be Well Clinical Studies - Omaha · Omaha, NE

New Jersey · 1

  • Ocean Medical Research · Toms River, NJ

New York · 4

  • University at Buffalo - UBMD Neurology · Buffalo, NY
  • The Feinstein Institute for Medical Research · Manhasset, NY
  • Mid Hudson Medical Research · New Windsor, NY
  • Research Central LLC (DBA Ichor Research) · Syracuse, NY

North Carolina · 2

  • New Hope Clinical Research · Charlotte, NC
  • UNC Health REX Hospital · Raleigh, NC

Ohio · 1

  • Cleveland Clinic · Cleveland, OH

Pennsylvania · 1

  • Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience · Philadelphia, PA

Tennessee · 2

  • Neurology Clinic, P.C. · Cordova, TN
  • Vanderbilt University Medical Center- Village · Nashville, TN

Texas · 5

  • Pinnacle Clinical Research · Austin, TX
  • Horizon Clinical Research Center - Houston · Cypress, TX
  • ANESC Research · El Paso, TX
  • Stryde Research - Plano · Plano, TX
  • Be Well Clinical Studies · Round Rock, TX

Utah · 1

  • Boeson Research - Provo · Provo, UT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.